Marex Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404K Buy
74,772
+44,445
+147% +$266K ﹤0.01% 682
2025
Q4
$211K Sell
30,327
-23,206
-43% -$153K ﹤0.01% 833
2025
Q3
$345K Buy
+53,533
New +$366K ﹤0.01% 590
2023
Q2
Sell
-44,798
Closed -$363K 238
2023
Q1
$363K Buy
44,798
+1,630
+4% +$13.1K 0.05% 180
2022
Q4
$271K Buy
+43,168
New +$302K 0.04% 206

Other funds holding BHC

Marex Group's BHC Position: Q1 2026 in Review

Marex Group increased its Bausch Health (BHC) stake by 147% in Q1 2026, buying an estimated $266K and bringing the position to 74,772 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Marex Group first reported a position in BHC in Q4 2022 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Marex Group held 74,772 shares of Bausch Health worth $404K as of Q1 2026.
  • Marex Group bought 44,445 Bausch Health shares in Q1 2026, an estimated $266K.
  • Bausch Health made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #682 holding.
  • Marex Group first reported a position in Bausch Health in Q4 2022 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.